Angiogenic gene cell therapy using suicide gene system regulates the effect of angiogenesis in infarcted rat heart

Transplantation

Volumn 81, Issue 6, 2006, Pages 902-907

  Miyagawa, Shigeru ^a   Sawa, Yoshiki ^a   Fukuda, Keiichi ^b   Hisaka, Yasuyo ^b   Taketani, Satoshi ^a   Memon, Imran Ahmed ^a   Matsuda, Hikaru ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gene therapy; Heart failure; HGF; Myocardial infarction

Indexed keywords

COMPLEMENTARY DNA; GANCICLOVIR; SCATTER FACTOR; THYMIDINE KINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CELL PROLIFERATION; CELL STRAIN 3T3; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CULTURE MEDIUM; FETUS; GENE EXPRESSION; HEART INFARCTION; HEART PERFORMANCE; HERPES SIMPLEX VIRUS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PLASMID; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; SUICIDE GENE THERAPY; TUMOR GROWTH;

ANIMALS; FIBROBLASTS; GANCICLOVIR; GENE THERAPY; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MICE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; NIH 3T3 CELLS; RATS; THYMIDINE KINASE; TRANSFECTION;

EID: 33645642667     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000202843.86864.10     Document Type: Article

References (25)

1. American Heart Association. Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association 2001.
2. Mann DL. Mechanisms and models in heart failure. Circulation 1999; 100: 999-1008
3. Simons M, Bonow RO, Chronos NA, et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. Circulation 2000; 102: E73-E86.
4. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003; 41: 1078-1083.
5. Pagani FD, DerSimonian H, Zawadzka A, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003; 41: 879-888.
6. Funatsu T, Sawa Y, Ohtake S, et al. Therapeutic angiogenesis in the ischemic canine heart induced by myocardial injection of naked complementary DNA plasmid encoding hepatocyte growth factor. J Thorac Cardiovasc Surg 2002; 124: 1099-105.
7. Roguin A, Avivi A, Nitecki S, et al. Restoration of blood flow by using continuous perimuscular infiltration of plasmid DNA encoding subterranean mole rat Spalax ehrenbergi VEGF. Proc Natl Acad Sci U S A 2003; 100: 4644-4648.
8. Mack CA, Patel SR, Schwarz EA, et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for VEGF 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 1998; 115: 168-177.
9. Suzuki K, Murtuza B, Smolenski RT, et al. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 2001; 104: I207-I212.
10. Isner JM. Myocardial gene therapy. Nature 2002; 415: 234-239.
11. Lee RJ, Springer ML, Blanco-Bose, et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000; 102: 898-901.
12. Tyynela K, Sandmair AM, Turunen M, et al. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model. Cancer Gene Ther 2002; 9: 917-924.
13. Maeda M, Moriuchi S, Sano A, et al. New drug delivery system for water-soluble drugs using silicone and its usefulness for local treatment: application of GCV-silicone to GCV/HSV-tk gene therapy for brain tumor. J Controlled Release 2002; 13: 15-25.
14. Cohen JL, Boyer O, Klatzmann D. Suicide gene therapy of graft-versus-host disease: immune reconstitution with transplanted mature T cells. Blood 2001; 61: 2071-2076.
15. Hisaka Y, Ieda M, Nakamura T, et al. Powerful and controllable angiogenesis by using gene-modified cells expressing human hepatocyte growth factor and thymidine kinase. J Am Coll Cardiol 2004; 19; 43(10): 1915-1922.
16. Nakamura T, Mizuno S, Matsumoto K, et al. Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 2000; 106(12): 1511-1519.
17. Weisman HF, Bush DE, Mannisi JA, et al. Cellular mechanism of myocardial infarct expansion. Circulation 1988; 78: 186-201.
18. McKnight SL. The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene. Nucleic Acids Res 1980; 8: 5949-5964.
19. Gorcsan J 3rd, Morita S, Mandarino WA, et al. Two-dimensional Echocardiographic Automated Border Detection Accurately Reflects Changes in Left ventricular Volume. J Am Soc Echocardiogr 1993; 6: 482-489.
20. Vale PR, Losordo DW, Milliken CE, et al. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 2000; 102: 965-974.
21. Khan TA, Sellke FW, Laham RJ. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia. Gene Ther 2003; 10: 285-291.
22. Masaki I, Yonemitsu Y, Yamashita A, et al. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res 2002; 90: 966-973.
23. Shyu KG, Chang H, Wang BW, et al. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia. Am J Med 2003; 114: 85-92.
24. Miyagawa S, Sawa Y, Taketani S, et al. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation 2002; 105: 2556-2561.
25. Desaknai S, Lumniczky K, Esik O, et al. Local tumour irradiation enhances the anti-tumour effect of a double-suicide gene therapy system in a murine glioma model. J Gene Med 2003; 5: 377-385.